Market News

Stay updated with the latest market trends, earnings, and economic indicators.

Showing news for:MOGSECHealthcare
Clear all filters
HDFC Life buys Rs 153 crore Motilal Oswal Financial shares, promoter sells 4.5% stake in NRB Bearings
positive
Moneycontrol NaNd ago

HDFC Life buys Rs 153 crore Motilal Oswal Financial shares, promoter sells 4.5% stake in NRB Bearings

Motilal Oswal Healthcare Foundation, and Motilal Oswal Foundation were sellers in Motilal Oswal Financial Services shares.

HCGHCG-REHDFCLIFEHEALTHCAREHEALTHYJMFINANCILMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUENIBLCapital GoodsFinancial Services
Buy Ipca Laboratories; target of Rs 1730: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Ipca Laboratories; target of Rs 1730: Motilal Oswal

Motilal Oswal is bullish on Ipca Laboratories recommended buy rating on the stock with a target price of Rs 1730 in its research report dated June 01, 2026.

IPCALABMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUEFinancial ServicesHealthcare
Buy Dr Agarwals Health Care; target of Rs 610: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Dr Agarwals Health Care; target of Rs 610: Motilal Oswal

Motilal Oswal is bullish on Dr Agarwals Health Care recommended buy rating on the stock with a target price of Rs 610 in its research report dated Jun 05, 2026.

AGARWALEYEAMRUTANJANMEDANTAMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUEPGHHZOTAFast Moving Consumer GoodsFinancial Services
Buy Star Health; target of Rs 640: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Star Health; target of Rs 640: Motilal Oswal

Motilal Oswal is bullish on Star Health has recommended buy rating on the stock with a target price of Rs 640 in its research report dated April 29, 2026.

MEDANTAMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUESTARSTARHEALTHFinancial ServicesHealthcare
Buy Rubicon Research; target of Rs 955: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Rubicon Research; target of Rs 955: Motilal Oswal

Motilal Oswal is bullish on Rubicon Research recommended buy rating on the stock with a target price of Rs 955 in its research report dated April 15, 2026.

MOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUERUBICONFinancial ServicesHealthcare
Buy Piramal Pharma; target of Rs 190: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Piramal Pharma; target of Rs 190: Motilal Oswal

Motilal Oswal is bullish on Piramal Pharma has recommended buy rating on the stock with a target price of Rs 190 in its research report dated April 29, 2026.

MOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUEPPLPHARMASPARCFinancial ServicesHealthcare
Buy Rubicon Research; target of Rs 1160: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Rubicon Research; target of Rs 1160: Motilal Oswal

Motilal Oswal is bullish on Rubicon Research recommended buy rating on the stock with a target price of Rs 1160 in its research report dated May 30, 2026.

MOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUERUBICONFinancial ServicesHealthcare
Buy Mankind Pharma; target of Rs 2640: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Mankind Pharma; target of Rs 2640: Motilal Oswal

Motilal Oswal is bullish on Mankind Pharma has recommended buy rating on the stock with a target price of Rs 2640 in its research report dated April 29, 2026.

MANKINDMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUESPARCFinancial ServicesHealthcare
Buy Laurus Labs; target of Rs 1280: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Laurus Labs; target of Rs 1280: Motilal Oswal

Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 1280 in its research report dated March 19, 2026.

LAURUSLABSMOALPHA50MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUEFinancial ServicesHealthcare
Buy Granules India; target of Rs 820: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Granules India; target of Rs 820: Motilal Oswal

Motilal Oswal is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 820 in its research report dated April 29, 2026.

GRANULESMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUEFinancial ServicesHealthcare
Neutral ALKEM Laboratories; target of Rs 5840: Motilal Oswal
positive
Moneycontrol NaNd ago

Neutral ALKEM Laboratories; target of Rs 5840: Motilal Oswal

Motilal Oswal recommended Neutral rating on ALKEM Laboratories with a target price of Rs 5840 in its research report dated May 28, 2026.

ALKEMMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUEFinancial ServicesHealthcare
Buy Five Star Business Finance; target of Rs 600: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Five Star Business Finance; target of Rs 600: Motilal Oswal

Motilal Oswal is bullish on Five Star Business Finance has recommended buy rating on the stock with a target price of Rs 600 in its research report dated April 29, 2026.

FIVESTARLTFMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUESTARFinancial ServicesHealthcare